NASDAQ · Medical - Devices

VANI (VANI) Stock

$1.28 -1.54% NASDAQ: VANI Healthcare

Valuation

MetricValue
Price$1.28
Market Cap$110.38M
P/E Ratio-2.77
P/B Ratio4.39
P/S Ratio0.00
EPS (TTM)$-0.43
52-Week High$1.92
52-Week Low$0.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-168.75%
ROA-69.23%
ROCE-186.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.96
Current Ratio2.57

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-13.0M$-21.0M$-27.0M$-25.0M$-28.0M
Net Profit$-13.0M$-14.0M$-26.0M$-23.0M$-27.0M
EPS$-0.33$-0.17$-0.50$-0.43$-0.43
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$5.0M$51.0M$46.0M$42.0M$39.0M
Total Liabilities$3.0M$7.0M$25.0M$24.0M$24.0M
Cash$2.0M$45.0M$21.0M$18.0M$16.0M
Borrowings$2.0M$1.0M$21.0M$19.0M$19.0M

Latest News

Vivani Medical Insider Bought Shares Worth $999,999, According to a Recent SEC Filing MT Newswires · Jul 16, 2026 Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal MarketBeat · Jul 15, 2026 Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026 GlobeNewswire · Jul 14, 2026 Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream GlobeNewswire · Jul 14, 2026 Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal Simply Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-19.0M$-24.0M$-21.0M$-24.0M
Investing Cash Flow$-1.0M$-1.0M$-2.0M$-1.0M$-2.0M
Financing Cash Flow$0$55.0M$0$-19.0M$0
Net Cash Flow$0$44.0M$-24.0M$-2.0M$-2.0M
Free Cash Flow$-12.0M$-19.0M$-25.0M$-21.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-37.73%
Quick Ratio3.18
Interest Coverage—
Return 1Y-8.55%
Return 3Y12.10%
Return 5Y-87.74%

Ownership

Insiders Held57.94%
Institutions Held6.48%
Institutions Float Held15.41%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC1,530,9332026-03-31
Tanager Wealth Management LLP641,0852026-03-31
Geode Capital Management, LLC600,5782026-03-31
Tudor Investment Corp Et Al426,3022026-03-31
UBS Group AG337,7492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRDL $1.36 +1.49% -3.38 $156.77M 0.00%
EDAPEdap Tms S.a. $4.76 -0.52% -6.63 $178.23M 0.00%
FONR $19.09 +0.00% 15.33 $117.76M 0.00%
HYPR $0.94 +0.99% -3.44 $78.94M 0.00%
IMA $5.69 +1.07% -1.49 $64.18M 0.00%

About VANI

VANI is led by CEO Adam Mendelsohn, employs 37 people, headquartered in US, publicly traded since 2014.

VANI stock trades at $1.28 with a market capitalization of $110.38M. The stock is valued at a price-to-earnings (P/E) ratio of -2.77, price-to-book of 4.39, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.92 and $1.92, and currently trades 33.3% below its 52-week high.

On profitability, VANI generates a return on equity (ROE) of -168.75%, return on capital employed of -186.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides